SUVRETTA CAPITAL MANAGEMENT, LLC bought BNTC

December 29, 2025 · Form 4 insider transaction

SUVRETTA CAPITAL MANAGEMENT, LLC bought 11,587 shares of BENITEC BIOPHARMA INC at $13.44 per share, a transaction worth $155.7K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 0 days after the transaction.

Direction

Acquired (buy-side)

11,587

Price

$13.44

Total value

$155.7K

InsiderSUVRETTA CAPITAL MANAGEMENT, LLC

RoleDirector, 10% owner

CompanyBENITEC BIOPHARMA INC (BNTC)

SecurityCommon stock, par value $0.0001 per share

Transaction codeP — Open-market purchase

Transaction dateDecember 29, 2025

Filing dateDecember 29, 2025

Shares owned after1,848,156

OwnershipIndirect

10b5-1 planNo

AmendedNo

Footnotes

Notes are included on Exhibit 99.1.; Notes are included on Exhibit 99.1.

View the original Form 4 on SEC EDGAR